Xolegel Articles
US FDA warns against use of PPI Prilosec with Plavix
18 November 2009
Strong Ph II data for Cougar's abiratenone
9 March 2009
Steifel acquires Barrier in $145M deal
30 June 2008
Barrier's 1st-qtr loss narrows 9%
12 May 2008
Stiefel Labs' Extina cleared in the USA
23 July 2007
Headlines 25 years ago this week....
29 January 2007
FDA approves Barrier's Xolegel
7 August 2006
Headlines 25 years ago this week....
26 July 2006
Barrier Therapeutics gains FDA approval for Sebazole NDA
19 December 2005
Connetics to resume Extina's development
20 June 2005
Barrier to file Sebazole NDA by mid-2005
10 January 2005
BAY 43-9006 can be used with other drugs
8 November 2004
Connetics' NDA for Extina accepted by FDA
19 April 2004
FDA panel wants more safety data on CV Therapeutics Ranexa
15 December 2003
Connetics files for approval of Extina
14 July 2003
Connetics sees 4th-qtr product revenues rise 50%
3 February 2003
Connetics profitable by "2nd-half 2003"
24 June 2002
Warnings To Be Added To US Propulsid Labeling
1 July 1998
Lipobay Selected For Large UK Study In Diabetics
24 June 1997
CSM Curbs Terfenadine Use In UK
5 May 1997
Carter-Wallace's Astelin Launched In USA
3 March 1997
HMR Launches Telfast 120 In The UK
3 March 1997
HMR Pushes Allegra As It Faces Possible Seldane Ban
20 January 1997
Fexofenadine Launched In Its First Market
2 September 1996
Triple Therapies For HIV Provide Encouraging Data
5 February 1996
EUROPEAN STOCK COMMENT
18 September 1995
USA's "Most Ever" Switches By Year-End?
14 August 1995
UK POM-To-P Switches At End-June
19 June 1995
Disease ManagementThe Way Forward
15 May 1995
Labelling Change For Cisapride
20 March 1995
Janssen-Cilag Issues Dear Doctor
13 March 1995
Four More POM-To-P Switches In UK
30 January 1995
$25 Bill Latin American Pharma Market In 2000
9 January 1995
France Cuts Drug Prices, Bans Promo Campaigns
5 September 1994
UNCERTAINTY OVER SWEDISH OTC PLANS
9 May 1994
MMD TO FILE SUIT OVER SELDANE FORM
14 March 1994
OTC KETOCONAZOLE IN THE USA
28 February 1994
NIZORAL TOPS SKIN DRUG LEAGUE IN 1992
10 January 1994
JAPAN NEWS IN BRIEF
10 January 1994
NEW NHI LIST ADDITIONS IN JAPAN
20 December 1993
NEW DATA ON SANDOZ' LAMISIL VS SPORANOX
4 October 1993
PENDING APPLICATIONS IN US CONTINUE TO DWINDLE
19 July 1993
UPJOHN BEWILDERED BY UK DoH DECISION
21 June 1993
SEMPREX-D BACKED FOR HAYFEVER
17 May 1993
SPANISH FIRM ESTEVE INTERNATIONALIZES
10 May 1993
BROAD SPECTRUM WAY FORWARD IN ANTIFUNGALS
12 April 1993
TERFENEDINE AND KETOCONAZOLE STUDY
22 March 1993
SCHERING-PLOUGH'S CLARITYN GOES OTC
1 February 1993
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
EFALITH COMPARATIVE TRIAL DATA
3 August 1992
NEW FORMULATION OF JANSSEN'S NIZORAL
10 February 1992
Showing 1-57 of 57 articles
- 1
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
